Abstract:The high prevalence of hypertension in China is well known, with stroke being the most common cause of death and disability. 1 GBD 2013 Mortality and Causes of Death CollaboratorsGlobal, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385: 117-171 Summary Full Text Full Text PDF PubMed Scopus (5370) Google Scholar Two large nationwide studies reported in The Lancet2 Lu J Lu Y Wang X et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017; (published online Oct 25.)http://dx.doi.org/10.1016/S0140-6736(17)32478-9 Summary Full Text Full Text PDF Scopus (567) Google Scholar , 3 Su M Zhang Q Bai X et al. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet. 2017; (published online Oct 25.)http://dx.doi.org/10.1016/S0140-6736(17)32476-5 Summary Full Text Full Text PDF Scopus (82) Google Scholar highlight that although the prevalence of hypertension in China is similar to that suggested in previous studies, it is simple deficiencies in the country's health system that make a large contribution to the disease burden. Both studies used data from the PEACE (Patient-Centred Evaluative Assessment of Cardiac Events) Million Persons Project (MPP), which enrolled 1·7 million adults aged 35–75 years from across China. This is a population-centred, national screening initiative to detect populations at high risk of cardiovascular disease. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)Among Chinese adults aged 35–75 years, nearly half have hypertension, fewer than a third are being treated, and fewer than one in twelve are in control of their blood pressure. The low number of people in control is ubiquitous in all subgroups of the Chinese population and warrants broad-based, global strategy, such as greater efforts in prevention, as well as better screening and more effective and affordable treatment. Full-Text PDF Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional surveyChina has marked deficiencies in the availability, cost, and prescription of antihypertensive medications. High-value medications are not preferentially used. Future efforts to reduce the burden of hypertension, particularly through the work of primary health-care providers, will need to improve access to, and use of, antihypertensive medications, paying particular attention to those with high value. Full-Text PDF

Elevated Blood Pressure and Headache Disorders in China – Associations, Under-Treatment and Implications for Public Health

Headache care in China.

Headache Care in China

Hypertension in China: the Gap Between Policy and Practice

Status of diagnosis and preventative treatment for primary headache disorders: real-world data of unmet needs in China

Association Between Migraine or Severe Headache and Hypertension among US Adults: A Cross-Sectional Study

Burden of headache disorders in China, 1990–2017: findings from the Global Burden of Disease Study 2017

Abstract 005: Prevalence, Awareness, Treatment, and Control of Hypertension in China: The China Metabolic Risk Factor Study

Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study

Prevalence, Awareness, Treatment, and Control of Hypertension in China: Results from a National Survey.

Impact of the National Essential Public Health Services Policy on Hypertension Control in China

Burden of hypertension in China over the past decades: Systematic analysis of prevalence, treatment and control of hypertension

Hypertension in China: Past, Present, and Future

Factors associated with awareness, treatment and control of hypertension among 3579 hypertensive adults in China: data from the China Health and Nutrition Survey

Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study

Associated Factors with Awareness, Treatment and Control of Hypertension among 3,579 Hypertensive Adults in China: Data from the China Health and Nutrition Survey

Quality in screening and measuring blood pressure in China's primary health care: a national cross-sectional study using unannounced standardized patients

Prevalence of Hypertension in China: a Cross-Sectional Study.

Barriers to Blood Pressure Control in China in a Large Opportunistic Screening.

Prevalence, treatment, and attributed mortality of elevated blood pressure among a nationwide population-based cohort of stroke survivors in China

Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey